Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Current "Attitude"

Stop the share buyback, and stop actions toward making an acquisition happen. Suddenly he may have recognized that money may have to be stretched while awaiting a USPTO outcome.

Again I ask what outcome?? All three patent re-exams? How long will the wait be? One won't speed up this process will it? IMO we'll need all three completed if what you speculate about a contingency is true.

Share
New Message
Please login to post a reply